Reducing Neurotoxicity in Lung Cancer
Laurie Gaspar, MD, discusses reducing neurotoxicity in small cell lung cancer patients.
Laurie Gaspar, MD, Professor and Chair Department of Radiation Oncology, Grohne Chair in Clinical Oncology, University of Colorado School of Medicine, discusses reducing neurotoxicity in small cell lung cancer patients.
Clinical Pearls
- Neurotoxicity is a phenomenon that occurs with prophylactic cranial radiation or whole brain radiation therapy for brain metastases
- There are several methods of decreasing neurotoxicity, but using medication seems to be the most straightforward approach
- Additional research is being done to focus on reducing or avoiding radiation to the hippocampus, which will help patients keep their memory
Recent Videos
Related Content
Advancing Neoadjuvant Therapy for HER2+ Breast Cancer Through ctDNA Monitoring
December 19th 2024Article
In an interview with Targeted Oncology, Adrienne Waks, MD, provided insights into the significance of the findings from the DAPHNe trial and their clinical implications for patients with HER2-positive breast cancer.
Read More
